SALELECTROSTIM: Treatment of Salivary Gland Hypofunction With Neuro- Electrostimulation

Sponsor
Universidad Autonoma de Nuevo Leon (Other)
Overall Status
Unknown status
CT.gov ID
NCT01174329
Collaborator
(none)
14
1
2

Study Details

Study Description

Brief Summary

The objective of the study is to evaluate with clinical parameters the performance of Saliwell Crown as a neuro-electrostimulator of the submandibular and sublingual salivary glands in hypofunction status due to polypharmacy or Sjögren's Syndrome in patients with symptoms of xerostomia.

Condition or Disease Intervention/Treatment Phase
  • Device: Automatic neuro-electrostimulation by "Saliwell Crown"
  • Device: Patient-regulated neuro-electrostimulation by "Saliwell Crown"
Phase 2/Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
14 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Difference in Salivary Flow in Patients With Salivary Gland Hypofunction of the Following Application of Neuro-electrostimulation
Study Start Date :
Aug 1, 2010
Anticipated Primary Completion Date :
Dec 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patient-regulated neuro-electrostimulation by "Saliwell Crown"

Patient regulated (by a remote control) neuro-electrostimulation by "Saliwell Crown"

Device: Patient-regulated neuro-electrostimulation by "Saliwell Crown"
On-demand stimulation of the lingual nerveby "Saliwell Crown"

Active Comparator: Automatic neuro-electrostimulation by "Saliwell Crown"

No remote control used

Device: Automatic neuro-electrostimulation by "Saliwell Crown"
Continuous stimulation of the lingual nerve by "Saliwell Crown"

Outcome Measures

Primary Outcome Measures

  1. self-reported xerostomia [4 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age range between 18 and 75 years of age

  • Clinical symptoms of xerostomia

  • Difference in whole salivary flow between resting and stimulating conditions

  • Patient ASA type I to III

  • Absence of at least one mandibular third molar inferior, but at least partially dentated in the mandible

Exclusion Criteria:
  • Patients with antimicrobial treatments in the three previous months

  • Smokers

  • Intake of bisphosphonates

  • Limitation of mandibular opening

  • Interoclusal distance smaller than 10 millimetres

  • Lack of adequate bone availability for implant placement

Contacts and Locations

Locations

Site City State Country Postal Code
1 C.D. Especialidad de Periodoncia Monterrey Nuevo León Mexico

Sponsors and Collaborators

  • Universidad Autonoma de Nuevo Leon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01174329
Other Study ID Numbers:
  • 1234
First Posted:
Aug 3, 2010
Last Update Posted:
Aug 18, 2010
Last Verified:
Jul 1, 2010
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2010